3.99 USD
↗ 0.11 (2.84%)AT CLOSE (11:59 AM EDT)
Galectin Therapeutics Inc.
GALTNASDAQ • USD
4.00
↗ 0.01 (0.25%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
4.00
↗ 0.01 (0.25%)
Market: OPEN
Galectin Therapeutics Inc. (GALT) trades at $4.00 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (20.2%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Aug 25, 2026.
Open?$4.07
High?$4.19
Low?$3.85
Prev. Close?$3.88
Volume?194.7K
Avg. Volume?433.4K
VWAP?$3.95
Rel. Volume?0.45x
Bid / Ask
Bid?$3.39 × 100
Ask?$4.56 × 100
Spread?$1.17
Midpoint?$3.97
Valuation & Ratios
Market Cap?391.3M
Shares Out?100.8M
Float?43.7M
Float %?66.3%
P/E Ratio?N/A
P/B Ratio?-2.82
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Employees
9
Market Cap
391.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2002-09-04
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD
NORCROSS, GA 30071
Phone: 678-620-3186
NORCROSS, GA 30071
Phone: 678-620-3186
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-55.20Distress
Confidence?59%Low
Short InterestSqueeze Risk
Short % of Float?20.61%Squeeze Risk
Short Interest?9.0M
Days to Cover?21.6
Free Float43.7M
Avg Daily Volume417.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?0.10Weak
Quick Ratio?0.10Weak
Cash Ratio?0.09Low
Debt/Equity?-0.24Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-2.82CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-26.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?20.2%STRONG▾
Peers50
S&P66
ROA?-189.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15889000
Enterprise Value?$411.1M
Fundamentals ratios updated end of day